
Patellar tendon or patellar ligament: what it is, what it does, and what the evidence says about its injuries
The patellar tendon, also called the patellar ligament, connects the kneecap to the shinbone and is part of the knee’s extensor mechanism. We explain where it is located, its most common injuries, patellar tendinopathy or jumper’s knee and tears, and what the scientific evidence says about its repair.

International patients at Teknon Hospital in Barcelona: what to know before considering an advanced cell therapy medicinal product
Teknon Hospital in Barcelona: what international patients should know before considering an advanced cell therapy medicinal product with cultured mesenchymal cells (CMC). We explain what the AEMPS requires, what documentation ITRT reviews remotely (MRI and medical history), and how consultations are organized at Centro Médico Teknon.

Herniated disc without nerve compression: is there a treatment that structurally regenerates the intervertebral disc?
When a herniated disc does not compress any nerve root, physical therapy and surgery relieve the symptom but do not act on the disc. What the scientific evidence says about structural regeneration of the intervertebral disc with Cultured Mesenchymal Cells (CMC), and which questions remain open.

Rotator cuff: what the evidence shows, and what an advanced cell therapy medicine with cultured MSCs (CMC) actually is
A rotator cuff tear (usually of the supraspinatus tendon) does not always respond to physical therapy and corticosteroid injections. We review what the scientific evidence says and what distinguishes, from a regulatory standpoint, an advanced cell therapy medicine with cultured mesenchymal cells (CMC) from a same-day cell concentrate.

Why does the Achilles tendon hurt and how to treat the pain?
We review the causes of Achilles tendon pain, the most common types of injury, and available treatment options — from conservative management to advanced cell therapy medicinal products with CMC.

Knee osteoarthritis: when surgery isn’t your only option
Is surgery the only option for advanced knee osteoarthritis? We review what gonarthrosis is, what the clinical evidence shows on cultured mesenchymal cells (CMC), and what requirements ITRT applies when evaluating alternatives authorized by the AEMPS.

The role of AEMPS in advanced cell therapy drugs
The AEMPS supervises the full lifecycle of advanced cell therapy medicinal products with cultured mesenchymal cells (CMC): clinical trials, GMP manufacturing, clinical application, and pharmacovigilance.

Chronic patellar tendinopathy: what sets cultured mesenchymal cells (CMC) apart from PRP?
Chronic patellar tendinopathy that does not respond to conventional treatments now has a clinical alternative backed by evidence: cultured mesenchymal cells (CMC). We explain what sets them apart from PRP and why the distinction matters.

La Vanguardia: regenerative therapies restore Achilles tendon rupture without surgery
The major paradigm shift in the treatment of this injury has been the introduction of cultured mesenchymal cells, administered percutaneously under deep sedation.

Cellular dose in cultured mesenchymal cells (CMC): why it is the parameter that changes everything
Before undergoing any procedure involving mesenchymal cells, there is one question that should be answerable with documentation: how many cells will be administered, and how has that number been verified? If no concrete answer exists, the procedure is not classified as a regulated medicinal product. The cellular dose is the technical and regulatory criterion that marks that difference. In this article, we explain how it is defined, how it is certified, and why it is decisive in indications such as tendons, cartilage, and lumbar disc disease, from the clinical and scientific perspective of ITRT.

Knee osteoarthritis: clinical evidence and structural regeneration with cultured mesenchymal cells (CMC)
Current research analyzes how to intervene in damaged structures in cases of knee osteoarthritis through advanced therapy medicinal products with cultured mesenchymal cells (CMC), evaluated in authorized clinical trials. Addressing how to regenerate cartilage requires distinguishing between non-regulated procedures and medicines developed under European regulatory standards.

Cultured mesenchymal cells: regulatory, biological, and clinical differences compared to same-day cell concentrates
The production of cultured mesenchymal cells (CMC) in a GMP cleanroom transforms a biological material into an advanced therapy medicinal product under quality control and regulatory supervision.

Which cellular treatments are considered legal and regenerative?
European and Spanish legislation establishes that only advanced therapy medicinal products used within the AEMPS framework can be considered regenerative cellular treatments. This article explains how to distinguish regulated medical interventions from unauthorized practices that use human cells without clinical evidence or legal approval, offering an analysis within the framework of Regulation (EC) No 1394/2007 and ITRT’s clinical experience.

Clinical advances in patellar tendinopathy: application of advanced therapy with Cultured Mesenchymal Cells (CMC)
Cultured Mesenchymal Cells (CMC) are applied within AEMPS-authorized clinical protocols to support structural and functional recovery of the patellar tendon in selected cases of chronic tendinopathy. Their use follows a regulated, personalized approach with GMP manufacturing and medical supervision.

ITRT presents evidence of tendon regeneration at the Swiss Medical Network Regenerative Day
Dr Robert Soler presented results from advanced therapy medicinal products authorized by AEMPS to a world-class international panel, positioning ITRT as a European reference in musculoskeletal regeneration

Regenerating the patellar tendon without surgery: clinical evidence with Cultured Mesenchymal Cells
Chronic patellar tendinopathy can be regenerated without surgery through advanced cell therapy. ITRT leads this approach with clinical evidence, regulated manufacturing, and over 450 doses administered using Cultured Mesenchymal Stem Cells (CMC).

Pseudoarthrosis: symptoms, early diagnosis, and advanced therapies with cultured mesenchymal cells
At ITRT, we address pseudoarthrosis with a rigorous clinical approach, combining expert diagnosis, scientific evidence, and advanced cellular therapies. We apply cultured mesenchymal cells (CMC) as an advanced therapy medicinal product, developed under GMP conditions and individually authorized by the AEMPS. Our therapeutic model ensures traceability, safety, and regulated clinical follow-up, focused on restoring bone function in non-healing fractures. Because each case requires precision, personalization, and real medicine.

Clinical trials with cultured mesenchymal cells: clinical results, scientific evidence, and new ITRT projects
ITRT’s clinical trials with cultured mesenchymal cells (CMC) have shown excellent results in the treatment of tissue injuries.

Truths and myths about mesenchymal cells in tendon regeneration
Scientific and regulatory information on the treatment of tendinopathies with advanced cell therapy products.

What should you ask before undergoing stem cell treatment? A safety guide for patients
At ITRT, we offer a clear guide before starting any cell-based treatment.
Don’t be misled—know the key questions to ask and ensure you’re receiving an authorized cell-based medicine with clinical evidence and regulated follow-up.

Common Achilles Tendon Injuries and Biological Treatment with Cultured Mesenchymal Cells (CMC)
The Use of Cultured Mesenchymal Cells (CMC) Is Essential in Regenerating the Achilles Tendon Across Various Types of Injuries.

Is It Possible to Regenerate the Supraspinatus Tendon?
The supraspinatus tendon supports joint mobility and provides stability. When injured, this critical function is compromised, often accompanied by chronic pain and daily activity limitations.

Chronic low back pain from lumbar disc degeneration: causes and regenerative treatment
Chronic low back pain is often associated with factors such as mechanical overload, disc aging, sedentary behavior, or long-term postural imbalances. These factors contribute to the progressive degeneration of the intervertebral discs in the lumbar region, a condition also known as black disc disease.

How to Regenerate the Patellar Tendon with Cultured Mesenchymal Cells?
Regenerating the patellar tendon through an advanced therapy medicinal product represents a significant breakthrough in personalized medicine. This tendon, which connects the patella to the tibia, plays a crucial role in knee mobility and stability.

Pau Gasol and his recovery journey to make it to the Tokyo Olympics
The case of Pau Gasol, one of the most prominent figures in Spanish sports and a former NBA player for 18 seasons, is particularly significant. Gasol was one of the

Cultured Mesenchymal Cells in Tissue Regeneration: Clinical Evidence from ITRT
Over the past decade, mesenchymal cells have emerged as one of the most promising solutions in regenerative medicine, particularly for tendon regeneration without surgery, delivering scientifically proven results. These cultured

Dr. Robert Soler presents Dani Pedrosa’s recovery through cultured mesenchymal cell therapy at Joint Challenge 2025
On March 21–22, the Grand Hotel Dino in Baveno, Italy, hosted Joint Challenge 2025—an international forum that brought together leading experts in orthopaedics, rheumatology, sports medicine and rehabilitation to explore

Presentation in Costa Rica
On August 7, Dr. Robert Soler Rich, Medical Director of the ITRT, gave the presentation “Treatment with cultured stem cells from bone marrow in diseases of the Locomotor System” in

ITRT presents clinical results in tendon with cultured mesenchymal cells (CMC)
The Institute of Tissue Regenerative Therapy (ITRT) has published in the American Journal of Sports Medicine the 6-month results of its clinical trial in chronic patellar tendinopathy with advanced cell